News
The company is leveraging its own portfolio and partner digital assets to directly engage patients at home, virtually or in-person.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
Also, Nordic nurse-tech pioneer to launch in the UK.
It will use the funds to deepen its presence across Asia.
The company has also launched a distribution unit in the United States.
The company plans to bring its technology to 10,000 more doctors in the country.
The round comes nearly a year after the company announced a $66 million Series C.
According to the Wall Street Journal's reporting, the Federal Trade Commission is investigating whether the startup was involved in deceptive or unfair marketing or advertising practices.
The deal will allow the company to offer a combination of in-person physical therapy and virtual coaching tools.
The all-cash deal is expected to close by the end of the year, subject to regulatory clearance.